The p53 inducing drug dosage may determine quiescence or senescence

類似資料

• Drugging in the absence of p53
  著者:: Aning, Obed Akwasi, 等
  出版事項: (2019)
• Exploiting the p53 Pathway for Therapy
  著者:: Cheok, Chit Fang, 等
  出版事項: (2017)
• The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
  著者:: Korotchkina, Lioubov G., 等
  出版事項: (2010)
• p53-based Cancer Therapy
  著者:: Lane, David P., 等
  出版事項: (2010)
• mTOR favors senescence over quiescence in p53-arrested cells
  著者:: Schug, Thaddeus T.
  出版事項: (2010)